Trillium Therapeutics Inc. (TRIL) Rose 6.94% or 0.42 To Price $6.55 On Wednesday


Trillium Therapeutics Inc. (TRIL) rose 6.94% or 0.42 to $6.55. It is near to 285714 shares traded, which is 594.69% compare to the average total volume 48044. The market cap of TRIL is $94.48 million. The year to date change is -15.77%. The 52 week price range is from $4.45 to $13.3. Price of TRIL have changed 2.51% during last week. It have changed 18.93% over last month, -1.21% over last 3 months, -19.93% over last 6 months and 34.62% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 5.50. It is -16.03% below current price. The 200-day Moving Averages for TRIL is 6.89. It is 5.19% above current price. The 52-week High is 13.3. It is 103.05% from the current price. The 52-week Low is 4.45. It is -32.06% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of TRIL is 2.98 on 2018-08-15. Short % to float is 0.92%. There are some statistics of TRIL. It is has market cap $94.48 million. The share outstanding is 14.42 million. The average volume is 48044. The percent of top 15 Institution holding is 40.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -256.20%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -52.25%.


Tags:

Share this post